Copper toxicity disease
Pro Research Analysisby 
Searched over 200M research papers
Copper Toxicity Disease: Mechanisms, Disorders, and Biomarkers
Introduction to Copper Toxicity
Copper (Cu) is an essential trace element involved in various biological processes, but its excess can lead to severe toxicity. The balance of copper in the body is maintained through a complex system of transporters and chaperone proteins. Disruption in this balance can result in copper toxicity, which is implicated in several diseases, including Wilson disease and neurodegenerative disorders 12.
Copper-Transport Diseases: Menkes and Wilson Disease
Menkes Disease
Menkes disease is a genetic disorder caused by mutations in the ATP7A gene, leading to copper deficiency. This condition results in poor copper absorption and distribution, causing severe developmental issues and neurological symptoms 16.
Wilson Disease
Wilson disease, on the other hand, is caused by mutations in the ATP7B gene, leading to copper accumulation in the liver and brain. This autosomal recessive disorder results in hepatic and neurological damage due to the toxic buildup of copper 168. The Atp7b-/- mouse model has shown that copper toxicity in Wilson disease also affects zinc-dependent proteins, indicating a broader impact on metal homeostasis .
Mechanisms of Copper Toxicity
Oxidative Stress and Cellular Damage
Copper toxicity is primarily attributed to its ability to generate reactive oxygen species (ROS) through Fenton or Haber-Weiss reactions. These ROS can cause oxidative damage to cellular components, including lipids, proteins, and DNA 2510. Excess copper can bind indiscriminately to thiol groups in proteins, disrupting their structure and function, which further contributes to cellular toxicity .
Mitochondrial Dysfunction
Recent studies have shown that excess copper can cause mitochondrial protein aggregation, leading to a distinct form of cell death. This mechanism involves the disruption of specific mitochondrial metabolic enzymes, which may explain the pathology associated with genetic copper overload disorders .
Copper-Induced Diseases
Hepatocerebral and Neurodegenerative Disorders
Excess copper is implicated in hepatocerebral disorders like Wilson disease and neurodegenerative diseases such as Alzheimer's and Parkinson's disease. The neurotoxicity of copper is linked to its ability to induce oxidative stress, alter lipid metabolism, and affect gene expression 245. Elevated levels of non-ceruloplasmin bound copper have been observed in both Wilson disease and Alzheimer's disease, suggesting its potential as a biomarker for copper toxicity .
Acute and Chronic Toxicity
Acute copper toxicity can lead to severe pathologies and even death, while chronic toxicity is associated with liver disease and neurological defects. Elevated ceruloplasmin levels are considered a risk factor for certain diseases, highlighting the importance of maintaining copper homeostasis .
Biomarkers and Diagnostic Challenges
Current Biomarkers
The most widely used biomarkers for diagnosing Wilson disease include serum/plasma copper, urine copper, and ceruloplasmin concentrations. However, these markers are not specific for copper excess as they can be influenced by various factors such as age, sex, and inflammation .
Emerging Biomarkers
Recent research has focused on identifying more specific biomarkers for copper neurotoxicity. Copper chaperone for superoxide dismutase and proteomics studies of cerebrospinal fluid are promising areas of investigation. These approaches aim to provide more accurate and early diagnosis of copper-induced neurotoxicity .
Conclusion
Copper toxicity is a complex condition resulting from the disruption of copper homeostasis, leading to severe health issues, including genetic disorders like Menkes and Wilson disease, and neurodegenerative diseases. Understanding the mechanisms of copper toxicity and identifying reliable biomarkers are crucial for early diagnosis and effective treatment. Continued research in this field is essential to uncover new therapeutic targets and improve patient outcomes.
Sources and full results
Most relevant research papers on this topic